ALNY icon

Alnylam Pharmaceuticals

185 hedge funds and large institutions have $4.6B invested in Alnylam Pharmaceuticals in 2014 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 62 increasing their positions, 69 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
185
Holders Change
-8
Holders Change %
-4.15%
% of All Funds
5.37%
Holding in Top 10
9
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+200%
% of All Funds
0.26%
New
21
Increased
62
Reduced
69
Closed
26
Calls
$49.7M
Puts
$49M
Net Calls
+$667K
Net Calls Change
+$5.07M
Name Holding Trade Value Shares
Change
Shares
Change %
BGA
201
Belmont Global Advisors
Texas
-$411K -6,500 Closed
Marshall Wace
202
Marshall Wace
United Kingdom
-$316K -5,000 Closed
Jane Street
203
Jane Street
New York
-$291K -4,601 Closed
TH
204
Timber Hill
Connecticut
-$287K -4,542 Closed
VKH
205
Virtu KCG Holdings
New York
-$246K -3,892 Closed
BFS
206
Bradley Foster & Sargent
Connecticut
-$221K -3,500 Closed
BJ
207
BlackRock Japan
Japan
-$68K -1,070 Closed
NIMI
208
Natixis Investment Managers International
France
-$63K -1,004 Closed
CIM
209
CenturyLink Investment Management
Colorado
-$60K -949 Closed
PAM
210
Panagora Asset Management
Massachusetts
-$43K -677 Closed
MWP
211
MYCIO Wealth Partners
Pennsylvania
-$32K -500 Closed